7 medtech stories we missed this week: May 12, 2017

[Image from unsplash.com]From Bioness’s new distribution deal to InBrace’s launch of new braces technology, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. Obalon receives approval to commercialize in Middle East Obalon Therapeutics announced in a May 11 press release that it has received regulatory approvals in select Middle East markets to commercialize its 6-month, gas-filled intragastric balloon system. The FDA-approved, swallowable balloon system is designed to treat obesity and is the first and only system of its kind. The regulatory approval also accounts for its associated inflation dispenser. Obalon Therapeutics plans to fulfill an initial order for its Middle East distributor Bader Sultan during the second quarter of 2017. 2. Biotronik touts home monitoring data Biotronik published results for its Home Monitoring system for ICD patients, according to a May 11 press release. The data showed that the system reduced the risk of all-cause mortality in ICD patients after one year by 38%. It also showed that there was a 36% reduction in the combined risk of all-cause mortality and hospitalization for heart failure. The study gathered data from 2,405 patients from the Trust, Ecost and In-time trials. In-time showed a more than 50% risk reduction in all-cause mortality in ICD and CRT-D patients who have symptomatic heart failure. 3. Bioness, Ottobock ink EU distribution deal Bioness and Ottobock announced in a May 10 pr...
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News Patient Monitoring Regulatory/Compliance Research & Development Surgical Bioness Inc. InBrace LensAR Inc. MedTech Obalon Therapeutics Ottobock SRS Medical Teleon Surgical ZipLine Medical Source Type: news